Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Valverde

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Alzheimer'S Disease : JAD|October 3, 2022
Photobiomodulation for Hypertension and Alzheimer's DiseaseAudrey Valverde, John Mitrofanis
Neural Regeneration Research|March 9, 2022
Aminopeptidase A and dipeptidyl peptidase 4: a pathogenic duo in Alzheimer's disease?Frédéric Checler, Audrey Valverde
The Journal of Biological Chemistry|August 26, 2018
Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?Julie Dunys, Audrey Valverde, Frédéric Checler
Neural Regeneration Research|August 26, 2022
Lights at night: does photobiomodulation improve sleep?Audrey Valverde, Catherine Hamilton, Cécile Moro, et al.
The Journal of Biological Chemistry|July 15, 2021
Dipeptidyl peptidase 4 contributes to Alzheimer's disease-like defects in a mouse model and is increased in sporadic Alzheimer's disease brainsAudrey Valverde, Julie Dunys, Thomas Lorivel, et al.
Acta Neuropathologica|April 21, 2021
Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brainAudrey Valverde, Julie Dunys, Thomas Lorivel, et al.
Cellular and Molecular Life Sciences : CMLS|March 17, 2023
The η-secretase-derived APP fragment ηCTF is localized in Golgi, endosomes and extracellular vesicles and contributes to Aβ productionElissa Afram, Inger Lauritzen, Alexandre Bourgeois, et al.
Frontiers in Neuroscience|August 15, 2022
The effect of photobiomodulation on the brain during wakefulness and sleepCecile Moro, Audrey Valverde, Marjorie Dole, et al.
Alzheimer'S Research & Therapy|June 2, 2025
Hampered AMPK-ULK1 cascade in Alzheimer's disease (AD) instigates mitochondria dysfunctions and AD-related alterations which are alleviated by metforminArnaud Mary, Samantha Barale, Fanny Eysert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Alzheimer'S Disease : JAD|October 3, 2022
Photobiomodulation for Hypertension and Alzheimer's DiseaseAudrey Valverde, John Mitrofanis
Neural Regeneration Research|March 9, 2022
Aminopeptidase A and dipeptidyl peptidase 4: a pathogenic duo in Alzheimer's disease?Frédéric Checler, Audrey Valverde
The Journal of Biological Chemistry|August 26, 2018
Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?Julie Dunys, Audrey Valverde, Frédéric Checler
Neural Regeneration Research|August 26, 2022
Lights at night: does photobiomodulation improve sleep?Audrey Valverde, Catherine Hamilton, Cécile Moro, et al.
The Journal of Biological Chemistry|July 15, 2021
Dipeptidyl peptidase 4 contributes to Alzheimer's disease-like defects in a mouse model and is increased in sporadic Alzheimer's disease brainsAudrey Valverde, Julie Dunys, Thomas Lorivel, et al.
Acta Neuropathologica|April 21, 2021
Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brainAudrey Valverde, Julie Dunys, Thomas Lorivel, et al.
Cellular and Molecular Life Sciences : CMLS|March 17, 2023
The η-secretase-derived APP fragment ηCTF is localized in Golgi, endosomes and extracellular vesicles and contributes to Aβ productionElissa Afram, Inger Lauritzen, Alexandre Bourgeois, et al.
Frontiers in Neuroscience|August 15, 2022
The effect of photobiomodulation on the brain during wakefulness and sleepCecile Moro, Audrey Valverde, Marjorie Dole, et al.
Alzheimer'S Research & Therapy|June 2, 2025
Hampered AMPK-ULK1 cascade in Alzheimer's disease (AD) instigates mitochondria dysfunctions and AD-related alterations which are alleviated by metforminArnaud Mary, Samantha Barale, Fanny Eysert, et al.
Pageof 1